Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus.

The Journal of Biological Chemistry
J Andrew N AlexanderNatalie C J Strynadka

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infections cause significant mortality and morbidity globally. MRSA resistance to β-lactam antibiotics is mediated by two divergons that control levels of a β-lactamase, PC1, and a penicillin-binding protein poorly acylated by β-lactam antibiotics, PBP2a. Expression of genes encoding these proteins is controlled by two integral membrane proteins, BlaR1 and MecR1, which both have an extracellular β-lactam-binding sensor domain. Here, we solved the X-ray crystallographic structures of the BlaR1 and MecR1 sensor domains in complex with avibactam, a diazabicyclooctane β-lactamase inhibitor at 1.6-2.0 Å resolution. Additionally, we show that S. aureus SF8300, a clinically relevant strain from the USA300 clone of MRSA, responds to avibactam by up-regulating the expression of the blaZ and pbp2a antibiotic-resistance genes, encoding PC1 and PBP2a, respectively. The BlaR1-avibactam structure of the carbamoyl-enzyme intermediate revealed that avibactam is bound to the active-site serine in two orientations ∼180° to each other. Although a physiological role of the observed alternative pose remains to be validated, our structural results hint at the presence of a secondary sulfate-binding ...Continue Reading

References

May 1, 1993·Antimicrobial Agents and Chemotherapy·C J Hackbarth, H F Chambers
Nov 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·D GolemiS Mobashery
Feb 13, 2004·The Journal of Biological Chemistry·Raquel García-CastellanosF Xavier Gomis-Rüth
Jun 25, 2004·Nucleic Acids Research·Todd J DolinskyNathan A Baker
Jul 16, 2004·The Journal of Antimicrobial Chemotherapy·Alain BonnefoyMaxime Lampilas
Aug 24, 2004·The Journal of Biological Chemistry·Mark S WilkeNatalie C J Strynadka
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Mar 23, 2006·Acta Crystallographica. Section D, Biological Crystallography·Jay Painter, Ethan A Merritt
Jul 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kanjana ThumanuChristopher Wharton
Mar 22, 2007·Proceedings of the National Academy of Sciences of the United States of America·Elena SantillanaAntonio Romero
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Dec 21, 2007·Acta Crystallographica. Section D, Biological Crystallography·Thomas C TerwilligerPaul D Adams
Feb 19, 2008·Journal of Chemical Information and Modeling·Junichi GotoNoriaki Hirayama
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Sep 2, 2009·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Oct 6, 2010·Antimicrobial Agents and Chemotherapy·Thérèse StachyraMichael T Black
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Martyn D WinnKeith S Wilson
Aug 24, 2011·Protein Engineering, Design & Selection : PEDS·Agnieszka SzareckaTroy Wymore
Sep 17, 2011·Journal of Chemical Information and Modeling·Roman A Laskowski, Mark B Swindells
Feb 9, 2012·FEMS Immunology and Medical Microbiology·Lance R ThurlowAnthony R Richardson
Apr 17, 2012·Acta Crystallographica. Section D, Biological Crystallography·Pavel V AfoninePaul D Adams
Jun 6, 2012·Annual Review of Biochemistry·Andrew L LoveringNatalie C J Strynadka
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·David E EhmannStewart L Fisher
Jun 26, 2013·Acta Crystallographica. Section D, Biological Crystallography·Philip R Evans, Garib N Murshudov
Jun 26, 2013·Acta Crystallographica. Section D, Biological Crystallography·Graeme WinterStephen M Prince
Oct 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Lisandro H OteroJuan A Hermoso
Dec 19, 2013·Infection and Drug Resistance·Christine MiossecMichael T Black
Jan 29, 2014·Antimicrobial Agents and Chemotherapy·Nuno T AntunesSergei B Vakulenko
Apr 4, 2014·Clinical Microbiology Reviews·Benjamin A Evans, Sebastian G B Amyes
Jul 22, 2014·IUBMB Life·Jennifer FishovitzShahriar Mobashery
Apr 26, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C MazuetM R Popoff
May 1, 2016·Nucleic Acids Research·Liisa Holm, Laura M Laakso
Jun 23, 2016·Cold Spring Harbor Perspectives in Medicine·Karen Bush, Patricia A Bradford
Apr 10, 2015·ACS Infectious Diseases·Dustin T KingNatalie C J Strynadka
Sep 17, 2016·Protein Science : a Publication of the Protein Society·Cynthia M JuneDavid A Leonard

❮ Previous
Next ❯

Citations

Nov 17, 2020·Frontiers in Molecular Biosciences·Sarah Wettstadt, María A Llamas
Jan 5, 2021·ACS Infectious Diseases·Nichole K StewartSergei B Vakulenko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.